MyFinsight
Home
Blog
About
Marketable securities
$48,523K
Cash and cash
equivalents
$4,868K
(-52.35%↓ Y/Y)
Accounts receivable
$2,042K
Prepaid expenses and
other current assets
$1,090K
(27.19%↑ Y/Y)
Total current assets
$56,523K
(410.46%↑ Y/Y)
Operating lease
right-of-use asset
$3,549K
(-19.12%↓ Y/Y)
Property and equipment,
net
$525K
(-54.11%↓ Y/Y)
Other assets
$246K
(-16.04%↓ Y/Y)
Total assets
$60,843K
(260.06%↑ Y/Y)
Total liabilities and
stockholders' equity
$60,843K
(260.06%↑ Y/Y)
Total stockholders'
(deficit)/equity
$47,985K
(624.25%↑ Y/Y)
Total liabilities
$12,858K
(-50.64%↓ Y/Y)
Total stockholders'
(deficit)/equity attributable to...
$39,234K
(803.75%↑ Y/Y)
Non-controlling interest
$8,751K
(344.58%↑ Y/Y)
Total current
liabilities
$10,638K
(-48.42%↓ Y/Y)
Operating lease
liability, less current...
$2,220K
(-30.60%↓ Y/Y)
Accumulated deficit
-$147,004K
(-25.79%↓ Y/Y)
Accumulated other
comprehensive gain
-$30K
(-1100.00%↓ Y/Y)
Additional paid-in capital
$186,255K
(67.38%↑ Y/Y)
Current portion of
deferred revenue
$5,123K
Accrued expenses and
other current...
$3,137K
(19.01%↑ Y/Y)
Current portion of
operating lease liability
$1,329K
(11.77%↑ Y/Y)
Accounts payable
$1,049K
(-41.66%↓ Y/Y)
Common stock,
value-Common Class A
$11K
(266.67%↑ Y/Y)
Common stock,
value-Common Class B
$2K
(0.00%↑ Y/Y)
Back
Back
Balance Sheet
Rani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. (RANI)
source: myfinsight.com